• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    6.70 Down 0.40(5.63%) 4:00PM EST
    |After Hours : 6.77 Up 0.07 (1.04%) 7:56PM EST
    Add to Portfolio
    Prev Close:7.10
    Open:7.09
    Bid:6.70 x 500
    Ask:6.80 x 200
    1y Target Est:7.50
    Beta:0.63
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:6.66 - 7.15
    52wk Range:6.52 - 10.26
    Volume:6,544,229
    Avg Vol (3m):3,180,190
    Market Cap:1.09B
    P/E (ttm):3.60
    EPS (ttm):1.86
    Div & Yield:0.60 (8.60%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 5.63%1.09B
    AMGNDown 2.96%117.53B
    SGENDown 0.79%4.39B
    XOMADown 2.33%383.40M

    Key Statistics

    Forward P/E (1 yr):8.48
    P/S (ttm):2.37
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.20
    Quarterly EPS Est (Mar-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback